# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-013877
Filing Date
2022-04-07
Accepted
2022-04-07 17:00:56
Documents
7
Period of Report
2022-05-16

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | pstv-def14a_20220516.htm | DEF 14A | 1216099
2 | GRAPHIC | gdtdc5zscevp000005.jpg | GRAPHIC | 11795
3 | GRAPHIC | gdtdc5zscevp000002.jpg | GRAPHIC | 11795
4 | GRAPHIC | gdtdc5zscevp000006.jpg | GRAPHIC | 768834
5 | GRAPHIC | gdtdc5zscevp000001.jpg | GRAPHIC | 49190
6 | GRAPHIC | gdtdc5zscevp000004.jpg | GRAPHIC | 11795
7 | GRAPHIC | gdtdc5zscevp000007.jpg | GRAPHIC | 470905
| Complete submission text file | 0001564590-22-013877.txt |  | 3037662

Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34375 | Film No.: 22814546
SIC: 3841 Surgical & Medical Instruments & Apparatus